Park Avenue Securities LLC grew its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 20.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 10,276 shares of the semiconductor company’s stock after acquiring an additional 1,732 shares during the period. Park Avenue Securities LLC’s holdings in Synopsys were worth $4,988,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of SNPS. Davidson Capital Management Inc. lifted its position in shares of Synopsys by 33,828.6% in the third quarter. Davidson Capital Management Inc. now owns 4,750 shares of the semiconductor company’s stock valued at $2,405,000 after acquiring an additional 4,736 shares in the last quarter. Peloton Wealth Strategists lifted its holdings in Synopsys by 221.2% in the 3rd quarter. Peloton Wealth Strategists now owns 2,881 shares of the semiconductor company’s stock valued at $1,459,000 after purchasing an additional 1,984 shares in the last quarter. Swiss National Bank boosted its stake in shares of Synopsys by 0.7% during the 3rd quarter. Swiss National Bank now owns 454,800 shares of the semiconductor company’s stock worth $230,306,000 after purchasing an additional 3,200 shares during the last quarter. Parnassus Investments LLC purchased a new stake in shares of Synopsys during the third quarter worth about $633,469,000. Finally, Harvest Portfolios Group Inc. raised its position in shares of Synopsys by 3.7% in the third quarter. Harvest Portfolios Group Inc. now owns 42,121 shares of the semiconductor company’s stock valued at $21,330,000 after buying an additional 1,496 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Synopsys
In other news, CRO Richard S. Mahoney sold 20,838 shares of the firm’s stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.66% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on SNPS
Synopsys Stock Performance
Shares of NASDAQ:SNPS opened at $515.81 on Friday. The stock has a 50-day simple moving average of $521.29 and a 200-day simple moving average of $527.29. The stock has a market capitalization of $79.73 billion, a P/E ratio of 35.52, a PEG ratio of 3.22 and a beta of 1.12. Synopsys, Inc. has a 1 year low of $457.52 and a 1 year high of $629.38.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Most active stocks: Dollar volume vs share volume
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Invest in the FAANG Stocks
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- 3 REITs to Buy and Hold for the Long Term
- Micron Technology: Riding the AI Wave to Long-Term Growth
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.